1. Home
  2. HIHO vs BFRI Comparison

HIHO vs BFRI Comparison

Compare HIHO & BFRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HIHO
  • BFRI
  • Stock Information
  • Founded
  • HIHO 1990
  • BFRI 1997
  • Country
  • HIHO Hong Kong
  • BFRI United States
  • Employees
  • HIHO N/A
  • BFRI N/A
  • Industry
  • HIHO Industrial Machinery/Components
  • BFRI Biotechnology: Pharmaceutical Preparations
  • Sector
  • HIHO Industrials
  • BFRI Health Care
  • Exchange
  • HIHO Nasdaq
  • BFRI Nasdaq
  • Market Cap
  • HIHO N/A
  • BFRI 8.7M
  • IPO Year
  • HIHO 1996
  • BFRI 2021
  • Fundamental
  • Price
  • HIHO $1.45
  • BFRI $0.81
  • Analyst Decision
  • HIHO
  • BFRI Strong Buy
  • Analyst Count
  • HIHO 0
  • BFRI 1
  • Target Price
  • HIHO N/A
  • BFRI $7.00
  • AVG Volume (30 Days)
  • HIHO 7.6K
  • BFRI 118.9K
  • Earning Date
  • HIHO 01-21-2025
  • BFRI 05-14-2025
  • Dividend Yield
  • HIHO 8.26%
  • BFRI N/A
  • EPS Growth
  • HIHO N/A
  • BFRI N/A
  • EPS
  • HIHO N/A
  • BFRI N/A
  • Revenue
  • HIHO $7,345,000.00
  • BFRI $37,321,000.00
  • Revenue This Year
  • HIHO N/A
  • BFRI $18.57
  • Revenue Next Year
  • HIHO N/A
  • BFRI $20.17
  • P/E Ratio
  • HIHO N/A
  • BFRI N/A
  • Revenue Growth
  • HIHO 11.36
  • BFRI 9.54
  • 52 Week Low
  • HIHO $1.39
  • BFRI $0.65
  • 52 Week High
  • HIHO $2.88
  • BFRI $2.42
  • Technical
  • Relative Strength Index (RSI)
  • HIHO 21.92
  • BFRI 44.98
  • Support Level
  • HIHO $1.39
  • BFRI $0.65
  • Resistance Level
  • HIHO $1.88
  • BFRI $0.96
  • Average True Range (ATR)
  • HIHO 0.05
  • BFRI 0.06
  • MACD
  • HIHO -0.05
  • BFRI -0.00
  • Stochastic Oscillator
  • HIHO 7.69
  • BFRI 50.65

About BFRI Biofrontera Inc.

Biofrontera Inc is a United States-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy (PDT) and topical antibiotics. Its licensed products are used for the treatment of actinic keratoses, which are pre-cancerous skin lesions, as well as impetigo, a bacterial skin infection. Its licensed product is Ameluz, which is a prescription drug approved for use in combination with the RhodoLED lamp series, for PDT (when used together, Ameluz PDT). including the complementary product BF-RhodoLED, and Xepi.

Share on Social Networks: